66 results on '"Pandya, Amit"'
Search Results
2. Economic Burden among Patients with Vitiligo in the United States: A Retrospective Database Claims Study
3. Effective and durable repigmentation for stable vitiligo: A randomized within-subject controlled trial assessing treatment with autologous skin cell suspension transplantation
4. Multimodality imaging of pancreas-kidney transplants
5. A retrospective cross-sectional analysis of gender and racial/ethnic diversity trends in dermatology chairs
6. Keratinocyte-Derived Chemokines Orchestrate T-Cell Positioning in the Epidermis during Vitiligo and May Serve as Biomarkers of Disease
7. Consensus on the safety and risks of laser and intense pulse light treatments in patients with vitiligo: An e-Delphi study
8. Diagnosed Prevalence and Incidence of Vitiligo in the United States: Analysis of Employer-Sponsored Insurance Claims
9. 51874 Reduction of Bother From Vitiligo Lesions on Different Areas of the Face and the Genitals Among Patients Receiving Upadacitinib During a Phase 2 Study
10. 53962 Efficacy of Povorcitinib for the Treatment of Vitiligo by Patient Demographics and Baseline Clinical Characteristics: Week 52 Subgroup Analysis From a Randomized, Placebo-Controlled, Phase 2b Clinical Trial
11. 53971 Correlation of Vitiligo Area Scoring Index With Vitiligo Extent Score-plus Responses in a Randomized, Double-Blinded, Placebo-Controlled, Dose-Ranging Phase 2b Study
12. Addition of Narrow-Band UVB Phototherapy to Ruxolitinib Cream in Patients With Vitiligo
13. New insight into adenosine receptors selectivity derived from a novel series of [5-substituted-4-phenyl-1,3-thiazol-2-yl] benzamides and furamides
14. Imaging in Infections of the Head and Neck
15. 111 - Hypopigmented disorders
16. Sézary syndrome cells overexpress syndecan-4 bearing distinct heparan sulfate moieties that suppress T-cell activation by binding DC-HIL and trapping TGF-β on the cell surface
17. Congenital Cystic Lesions of the Head and Neck
18. Poor prognosis in non-Caucasian patients with early-onset mycosis fungoides
19. Technique and diagnostic utility of saline infusion sonohysterography
20. 43978 Treatment-Emergent Adverse Events of Interest for Janus Kinase Inhibitors: Pooled Analysis of the 52-Week TRuE-V Phase 3 Studies of Ruxolitinib Cream Treatment for Vitiligo
21. 43959 Vitiligo Noticeability Scale Score Maintenance or Shift During 52 Weeks of Ruxolitinib Cream Treatment for Vitiligo: Pooled Analysis of the TRuE-V Phase 3 Studies
22. 43912 Facial Vitiligo Area Scoring Index Response Maintenance or Shift During 52 Weeks of Ruxolitinib Cream Treatment for Vitiligo: Pooled Analysis of the TRuE-V Phase 3 Studies
23. Consensus statement on definitions of disease, end points, and therapeutic response for pemphigus
24. Impact of short-term dermatology medical trips in the developing world
25. Melasma in Latina patients: Cross-cultural adaptation and validation of a quality-of-life questionnaire in Spanish language
26. Treatment of solar lentigines
27. Increasing our understanding of pigmentary disorders
28. A randomized, placebo-controlled trial of 5% and 2% topical minoxidil solutions in the treatment of female pattern hair loss
29. Imidazo[1,2-a]pyridines linked with thiazoles/thiophene motif through keto spacer as potential cytotoxic agents and NF-κB inhibitors
30. List of Contributors
31. Imiquimod 5% cream for the treatment of superficial basal cell carcinoma: A double-blind, randomized, vehicle-controlled study*
32. A simple and efficient approach for the synthesis of 2-aminated quinazoline derivatives via metal free oxidative annulation
33. 27636 Addition of narrow-band ultraviolet light B phototherapy to ruxolitinib cream in patients with vitiligo
34. 27568 Maintenance of repigmentation after discontinuation of ruxolitinib cream in patients with vitiligo
35. 27535 Safety and efficacy of ruxolitinib cream for the treatment of vitiligo: 104-week data from a phase 2 study
36. Implications of increasing publication trends in dermatology on individuals from disadvantaged backgrounds and those without a home dermatology program
37. PULSE INTRAVENOUS CYCLOPHOSPHAMIDE THERAPY FOR DERMATOLOGIC DISORDERS
38. NONTUBERCULOUS MYCOBACTERIAL INFECTIONS OF THE SKIN
39. DISORDERS OF HYPERPIGMENTATION
40. 17755 Global survey investigating the prevalence of vitiligo and vitiligo signs among adults in Europe, Japan, and the United States
41. 17752 Effects of ruxolitinib cream on affected body areas in patients with vitiligo: Subgroup analysis from a 52-week, randomized, double-blind trial
42. 17753 Analysis of 24-week response to ruxolitinib cream for the treatment of vitiligo based on patient demographics and clinical characteristics
43. Reply to the comment on “What are the barriers faced by underrepresented minorities applying to dermatology? A qualitative cross-sectional study of applicants applying to a large dermatology residency program”
44. Novel thiazole–thiophene conjugates as adenosine receptor antagonists: Synthesis, biological evaluation and docking studies
45. Silver-mediated synthesis of indolizines via oxidative C–H functionalization and 5-endo-dig cyclization
46. A concise synthesis of highly substituted imidazoles via copper-mediated oxidative C–H functionalization
47. Beware of Underlying Malignancy: Acquired Ichthyosis
48. An efficient one-pot synthesis of functionally diverse 2-aminothiazoles from isothiocyanates, amidines/guanidines and halomethylenes
49. A concise, greener, solvent-free novel one-pot synthesis of trisubstituted thiophenes
50. An efficient, greener, and solvent-free one-pot multicomponent synthesis of 3-substituted quinazolin-4(3H)ones and thienopyrimidin-4(3H)ones
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.